77 related articles for article (PubMed ID: 28384045)
1. Ectopic High Expression of E2-EPF Ubiquitin Carrier Protein Indicates a More Unfavorable Prognosis in Brain Glioma.
Zhang X; Zhao F; Zhang S; Song Y
Genet Test Mol Biomarkers; 2017 Apr; 21(4):242-247. PubMed ID: 28384045
[TBL] [Abstract][Full Text] [Related]
2. Combined aberrant expression of microRNA-214 and UBC9 is an independent unfavorable prognostic factor for patients with gliomas.
Wang S; Jiao B; Geng S; Ma S; Liang Z; Lu S
Med Oncol; 2014 Jan; 31(1):767. PubMed ID: 24277415
[TBL] [Abstract][Full Text] [Related]
3. Combined elevation of AURKB and UBE2C predicts severe outcomes and therapy resistance in glioma.
Alafate W; Zuo J; Deng Z; Guo X; Wu W; Zhang W; Xie W; Wang M; Wang J
Pathol Res Pract; 2019 Oct; 215(10):152557. PubMed ID: 31353228
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin-conjugating enzyme E2-EPF is overexpressed in cervical cancer and associates with tumor growth.
Liang J; Nishi H; Bian ML; Higuma C; Sasaki T; Ito H; Isaka K
Oncol Rep; 2012 Oct; 28(4):1519-25. PubMed ID: 22895574
[TBL] [Abstract][Full Text] [Related]
5. Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance.
Boustani MR; Mehrabi F; Yahaghi E; Khoshnood RJ; Shahmohammadi M; Darian EK; Goudarzi PK
J Neurol Sci; 2016 Apr; 363():80-3. PubMed ID: 27000226
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.
Guan Y; Chen L; Bao Y; Pang C; Cui R; Li G; Liu J; Wang Y
Int J Clin Exp Pathol; 2015; 8(1):727-34. PubMed ID: 25755767
[TBL] [Abstract][Full Text] [Related]
7. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
He J; Deng Y; Yang G; Xie W
J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin-conjugating enzyme E2-EPF is overexpressed in primary breast cancer and modulates sensitivity to topoisomerase II inhibition.
Tedesco D; Zhang J; Trinh L; Lalehzadeh G; Meisner R; Yamaguchi KD; Ruderman DL; Dinter H; Zajchowski DA
Neoplasia; 2007 Jul; 9(7):601-13. PubMed ID: 17710163
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of ubiquitin-specific protease 2a (USP2a) and nuclear factor erythroid 2-related factor 2 (Nrf2) in human gliomas.
Boustani MR; Khoshnood RJ; Nikpasand F; Taleshi Z; Ahmadi K; Yahaghi E; Goudarzi PK
J Neurol Sci; 2016 Apr; 363():249-52. PubMed ID: 27000259
[TBL] [Abstract][Full Text] [Related]
11. CREB3L1 and PTN expressions correlate with prognosis of brain glioma patients.
Liu LQ; Feng LF; Nan CR; Zhao ZM
Biosci Rep; 2018 May; 38(3):. PubMed ID: 29531016
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
13. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of midkine and pleiotrophin predicts poor survival in human glioma.
Ma J; Lang B; Wang X; Wang L; Dong Y; Hu H
J Clin Neurosci; 2014 Nov; 21(11):1885-90. PubMed ID: 25001988
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
[TBL] [Abstract][Full Text] [Related]
16. Concomitant microRNA-31 downregulation and radixin upregulation predicts advanced tumor progression and unfavorable prognosis in patients with gliomas.
Wang S; Jiao B; Geng S; Song J; Liang Z; Lu S
J Neurol Sci; 2014 Mar; 338(1-2):71-6. PubMed ID: 24380686
[TBL] [Abstract][Full Text] [Related]
17. Expression of ubiquitin-conjugating enzyme E2C/UbcH10 in astrocytic tumors.
Jiang L; Huang CG; Lu YC; Luo C; Hu GH; Liu HM; Chen JX; Han HX
Brain Res; 2008 Mar; 1201():161-6. PubMed ID: 18331723
[TBL] [Abstract][Full Text] [Related]
18. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of wild-type p53-induced phosphatase 1 confers poor prognosis of patients with gliomas.
Liang C; Guo E; Lu S; Wang S; Kang C; Chang L; Liu L; Zhang G; Wu Z; Zhao Z; Ma S; Wang L; Jiao BH
Brain Res; 2012 Mar; 1444():65-75. PubMed ID: 22325093
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of E2-EPF ubiquitin carrier protein in papillary renal cell carcinoma.
Roos FC; Evans AJ; Brenner W; Wondergem B; Klomp J; Heir P; Roche O; Thomas C; Schimmel H; Furge KA; Teh BT; Thüroff JW; Hampel C; Ohh M
Am J Pathol; 2011 Feb; 178(2):853-60. PubMed ID: 21281817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
